Who we are

Optimizing patient access to new interventions for all patients is the foundational pillar of our organization, as we lead market access and health economics projects for a broad range of for-profit and non-profit healthcare organizations. Our mission is to contribute to sustainable, cost-effective healthcare for all patients around the world, as we strongly believe that decision-making in the public and private healthcare sectors should be informed by evidence-based health economics and outcomes research (HEOR). Our team of experts have been doing exactly that, making academic insights understandable and user-friendly at the speed of business.

With the world population ageing, the incidence of most diseases rising, and healthcare expenditure reaching its limits, governments need an evidence-based method to assess the added value of innovative interventions. For patients, new interventions equal hope for increased longevity and improved quality of life, and it is crucial for governments and manufacturers that the process from patent to patient runs optimally and suffers no delays. After clinical trials demonstrate the efficacy of new interventions, it is up to us to get the intervention to patients by optimizing the market access process. We believe every undertaken HEOR project should add another piece of that puzzle; helping manufacturers and governments make informed decisions about new interventions leads to sustainable, cost-effective healthcare for patients.

Remember, if you have a HEOR-related question, you can just asc!

Our external advisory team brings fresh perspectives and expert insights, guiding us to tackle complex healthcare challenges. Their collaboration ensures our work is rigorous, impactful, and aligned with industry needs, helping us shape a healthier future.